Article

An American Journal of Managed Care® Symposium: Examining Treatment Advancements in Psoriasis and Psoriatic Arthritis

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Steven Daveluy, MD, dermatologist, Wayne State University
April Armstrong, MD, MPH, chief of dermatology, UCLA
April Armstrong, MD, MPH, chief of dermatology, UCLA
Related Content
Person reading on phone | Image credit: Farknot Architect - stock.adobe.com
September 12th 2025

Opportunities, Challenges in Digital Media and Psoriasis

Pearl Steinzor
Psoriasis as an Inflammatory Disease, and What’s Changed Over Time
September 12th 2025

Psoriasis as an Inflammatory Disease, and What’s Changed Over Time

Adalimumab | Image credit: luchschenF - stock.adobe.com
September 12th 2025

Infection Risk Higher in HS Compared With Psoriasis With Adalimumab

Pearl Steinzor
Psoriatic arthritis | Image credit: Oporty786 - stock.adobe.com
September 12th 2025

The Totality of Evidence of Ustekinumab Biosimilar SB17

Deana Ferreri, PhD
Psoriasis treatment concept | Sviatlana - stock.adobe.com
September 12th 2025

Beyond the Surface: How New Therapies, Patient-Centered Care Are Changing Psoriasis Outcomes

Pearl Steinzor
traffic-related air pollution | Sergiy Serdyuk - stock.adobe.com
September 12th 2025

Air Pollution, Genes Together Raise Psoriasis Risk, Study Finds

Pearl Steinzor

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo